semaglutide bimagrumab + plus alone or in combination for the treatment of obesity: a randomized phase 2 trial Next-Generation Myostatin Inhibitors: Bimagrumab, Trevogrumab, – Semaglutide (#wegovy/#Ozempic) + a muscle

( [ \- Link Opens in New Tab]( 07

Heart Health A healthy heart is a strong heart

[DOI] [PMC free article] [PubMed] [Google Scholar] 109.Viallard C., Larrive B

Stress can contribute to chronic disease, so learning how to manage stresslighten your allostatic loadcan dramatically improve your health

MENLO PARK, Calif., May 7, 2025 /PRNewswire/ -- Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, in partnership with Mayo Clinic researchers, presented new findings at Digestive Disease Week (DDW) 2025 showing its proprietary machine-learning algorithms can predict which patients are more likely to experience side effects, specifically nausea, from GLP-1 therapies

Semaglutide: A GLP-1 receptor agonist used primarily for type 2 diabetes management and weight loss management